
Sizibophezele emsebenzini wethu wokubhalisa abantu abasisiza ukuthuthukisa impilo yabantu abanomdlavuza. Ucwaningo lwezokwelapha lwethu lomdlavuza webele lucwaninga ngemithi ephenywayo yodwa, noma ngokuhambisana neminye imithi yocwaningo, noma ukwelapha kokunakekelwa okuvamile. Senza ucwaningo ukubona ukuthi lungasisiza yini ukuvimbela, ukuthola, noma ukwelapha umdlavuza.
Ezigulini ezingenayo i-receptor yehomoni yomdlavuza webele ophozethivu
Kunama-receptor amathathu ahlukene ngokuvamile atholakala kumaseli omdlavuza webele: i-estrogen receptor (ER), i-progesterone receptor (PR), kanye ne-human epidermal growth factor receptor 2 (HER-2). Lapho amahomoni we-estrogen ne-progesterone enamathela kulawa ma-receptor, aqala ukusebenza futhi abhebhethekisa ukukhula komdlavuza. I-HER-2 esebenzayo nayo ibhebhethekisa ukukhula komdlavuza. Lapho noma yimaphi lawa ma-receptor atholaka kumaseli, ukwelapha ngaphandle kwe-chemotherapy okuvimba lawa ma-receptor, njenge-hormone therapy noma ukwelapha okuqondene ne-HER-2, kusebenza kodwa noma ngokubambisana ne-chemotherapy ukubulala amaseli omdlavuza noma ukumisa ukukhula kwawo.
Ezigulini ezinomdlavuza webele oyi-tripple negative (TNBC)
Umdlavuza webele osesimweni se-tripple negative umelela u-10% kuya ku-15% wemidlavuza yebele. Ukuxilongwa kwe-TNBC kusho ukuthi amaseli omdlavuza aveze umphumela onegethivu kuma-receptor ama-3 ahlukene ngokuvamile atholakala kumaseli omdlavuza webele: i-estrogen receptor (ER), i-progesterone receptor (PR), kanye ne-human epidermal growth factor receptor 2 (HER-2).


